Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Viral Vector Manufacturing Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Viral Vector Manufacturing market report analyzes the Viral Vector Manufacturing market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
-
Regenerative Medicine Market Forecasts to 2028 – Global Analysis By Product (Progenitor and Stem Cell Therapies, Gene Therapies and Other Products), Material (Genetically Engineered Material, Synthetic material and Other Materials), Application (Oncology, Wound Care and Other Applications), End User and Geography
... Other Applications), End User and Geography According to Stratistics MRC, the Global Regenerative Medicine Market is accounted for $35.01 billion in 2022 and is expected to reach $73.94 billion by 2028 growing at a CAGR ... Read More
-
Gene Therapy Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... solid growth in the sector in 2023 and beyond. The Gene Therapy market report analyzes the Gene Therapy market growth opportunities, trends, insights, and market size outlook across types, applications, and countries. Gene Therapy market ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... Plasmid DNA Manufacturing industry is expected to register solid growth in the sector in 2023 and beyond. The Viral Vector and Plasmid DNA Manufacturing market report analyzes the Viral Vector and Plasmid DNA Manufacturing market ... Read More
-
Contract Research Organization (CRO) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines, Cell & Gene Therapy), End User & Region - Global Forecast to 2028
... The global CRO services market is estimated to grow at a CAGR of 10.7% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment ... Read More
-
Advanced Therapy Medicinal Products CDMO Market: Current Analysis and Forecast (2022-2028)
... Contract Development and Manufacturing Organization, is a company that provides services such as development, manufacturing, and quality control to support the production of ATMPs and other pharmaceutical products. The ATMP CDMO market is growing due ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market Intelligence Report - Global Forecast 2023-2030
... in 2022, at a CAGR 25.30% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support ... Read More
-
Gene Therapy Market Intelligence Report - Global Forecast 2023-2030
... forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In ... Read More
-
Viral and Non-Viral Vector Manufacturing Market: Current Analysis and Forecast (2022-2028)
... refers to the process of producing viral particles (typically viruses that have been modified) used as a delivery system for therapeutic genes. Non-viral vector manufacturing refers to the production of non-viral particles (such as nanoparticles, ... Read More
-
Cell & Gene Therapy Manufacturing Services Market Intelligence Report - Global Forecast 2023-2030
... in 2022, at a CAGR 15.73% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support ... Read More
-
North America Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product (Gene Therapy, Cell Therapy, and Tissue Engineered & Others), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Country and Growth Forecast, 2022 - 2028
... III, and Phase IV), By Country and Growth Forecast, 2022 - 2028 The North America Advanced Therapy Medicinal Products CDMO Market would witness market growth of 15.7% CAGR during the forecast period (2022-2028). Medications based ... Read More
-
Europe Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product (Gene Therapy, Cell Therapy, and Tissue Engineered & Others), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Country and Growth Forecast, 2022 - 2028
... and Phase IV), By Country and Growth Forecast, 2022 - 2028 The Europe Advanced Therapy Medicinal Products CDMO Market would witness market growth of 16.5% CAGR during the forecast period (2022-2028). The study of ATMPs ... Read More
-
Regenerative Medicine Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologic, Others); By Material (Synthetic Material, Biodegradable Synthetic Polymer, Scaffold, Others); By Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Others); By End User (Hospitals & Clinics, Commercial Industries, Government & Academic Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Scaffold, Others); By Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Others); By End User (Hospitals & Clinics, Commercial Industries, Government & Academic Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) ... Read More
-
Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product (Gene Therapy, Cell Therapy, and Tissue Engineered & Others), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Regional Outlook and Forecast, 2022 - 2028
... and Phase IV), By Regional Outlook and Forecast, 2022 - 2028 The Global Advanced Therapy Medicinal Products CDMO Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 16.3% ... Read More
-
Global Cancer Gene Therapy Market Size study & Forecast, by Type (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), by End Use (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others) and Regional Analysis, 2022-2029
... Therapy Market is valued at approximately USD 1.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 19.99% over the forecast period 2022-2029. Cancer gene therapy is a ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Allogeneic, Autologous, Viral Vector, Non-viral vector), Indication (Oncology, Orthopedic, Ophthalmology), Application (Clinical, Commercial), End User (Pharma, Biotech) - Global Forecast to 2027
... gene therapy manufacturing services market size is projected to reach USD 11.5 billion by 2027 from USD 5.1 billion in 2022, at a CAGR of 17.5% during the forecast period. Growth in this market can ... Read More
-
Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Gene Therapy sales for 2023 through 2029. With Osteoarthritis Gene Therapy sales broken down by region, market sector and sub-sector, this report ... Read More
-
RWE in Gene Therapy: Payer Views
... positive for new therapies that treat unmet clinical need there is a growing anxiety: can the cost of these novel therapies be afforded and justified? Payers want real-world evidence (RWE) that informs their decision making, ... Read More
-
COVID-19 Vaccine Market (Vaccine Type: mRNA, Viral Vector Vaccines (Adenovirus Vaccines, Inactivated Virus Vaccines, and Others), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Report TMR’s report on the global COVID-19 vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period ... Read More
-
Biologics Safety Testing Market by Product & Service (Instruments, Consumables, Services), Application (mAbs, Vaccine, Cell & Gene Therapy), Test Type (Sterility Test, Endotoxin, Mycoplasma, Bioburden), End User (Biopharma, CDMO) - Global Forecast to 2027
... global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics ... Read More
-
North America Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)
... Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and ... Read More
-
Viral Vector and Plasmid Dna Manufacturing Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... a CAGR of 23.38 % during the forecast period (2022-2027). The COVID-19 outbreak is expected to positively impact the viral vector and plasmid DNA manufacturing market. Several COVID-19 vaccine candidates entering clinical trials also include ... Read More
-
Plasmid DNA Manufacturing Market, By Product Type (Viral Vectors, Plasmid DNA and Non-viral Vectors), By Grade (GMP Grade, R&D Grade and Clinical Grade), By Application (DNA Vaccines, Gene Therapy, Immunotherapy, RNA Vaccines and Others), By Manufacturing Type (Outsourcing and In-house Manufacturing), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics and Marketed Therapeutics), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Manufacturing Type (Outsourcing and In-house Manufacturing), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics and Marketed Therapeutics), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity ... Read More
-
Gene Therapy Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... effect on the gene therapy market. Gene and cell therapy technology were extensively used in developing vaccines to treat COVID-19. For example, in January 2021, vaccine candidates developed by Mass General Brigham were made by ... Read More
-
Rare Disease Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 – 2028)
... USD 302,270 million at the end of the forecast period, registering a CAGR of 11.65%. The COVID-19 pandemic had a profound impact on the rare disease treatment market owing to the cancellations of elective procedures, ... Read More
Research Assistance
